By analyzing the relationship between the expression levels of FGF9 in CRC with various clinical-pathological parameters, we found that FGF9 expression was inversely associated with histodifferentiation (P<0.05, Fig. 4C). This evidence concerns the gene FGF9 and colorectal carcinoma.